Loading…
Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies
Urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents a non‐invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer‐related alterations in oxidative stress. We describe the development and validatio...
Saved in:
Published in: | Rapid communications in mass spectrometry 2009-01, Vol.23 (2), p.258-266 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873 |
---|---|
cites | cdi_FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873 |
container_end_page | 266 |
container_issue | 2 |
container_start_page | 258 |
container_title | Rapid communications in mass spectrometry |
container_volume | 23 |
creator | Teichert, Friederike Verschoyle, Richard D. Greaves, Peter Thorpe, James F. Mellon, J. Kilian Steward, William P. Farmer, Peter B. Gescher, Andreas J. Singh, Rajinder |
description | Urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents a non‐invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer‐related alterations in oxidative stress. We describe the development and validation of two separate liquid chromatography/tandem mass spectrometry (LC/MS/MS) selected reaction monitoring (SRM) methods for the determination of 8‐oxodG and creatinine in both murine and human urine using stable isotope labelled internal standards. Levels of 8‐oxodG were normalised to creatinine. The LC/MS/MS methods were applied to two chemoprevention studies utilising tea polyphenols in humans and TRAMP (TRansgenic Adenocarcinoma of the Mouse Prostate) mice. Patients with benign prostatic hyperplasia received 1 g/day of green tea polyphenols (GTP), 1 g/day of black tea theaflavins (BTT) or no treatment for 4 weeks. TRAMP mice received GTP (0.05% in drinking water) for 4 or 25 weeks. Prostate pathology in TRAMP mice was not affected by GTP. Levels of 8‐oxodG were not altered by tea polyphenols in either mice or humans. In TRAMP mice, urinary 8‐oxodG levels were elevated with increasing age (p |
doi_str_mv | 10.1002/rcm.3873 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_901667630</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>35353411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873</originalsourceid><addsrcrecordid>eNp90UGP1CAUAGBiNO7sauIvMJzUS3eh0NJ624y6a7JqNBtNvBBaXnfQAl1o1-nNP-TFn-QvkbGjnjQc4PE-XoCH0ANKjikh-Ulo7TGrBLuFVpTUIiM5o7fRitQFzTitqwN0GOMnQigtcnIXHdCaiLwq2Qp9ewYjBGucGo132He4yvzWZ_mPr98zDX47X03K-WgcYOU0bgMk6XahcdhO4XdiM1nl8BI3M-7N9WQS3wRv1eivgho288mYJFhsVYw4DtCOKQtjmJ9iNQy9aZdLjD6dA-uHADfgfm3FcdIG4j10p1N9hPv7-Qhdvnh-uT7PLt6cvVyfXmQtT6_KFADvVKdz6ERZsq5mbZVzWnKtlRBNydKi1jpvGq5EThqqGSUFbyg0QqRvPEKPl7JD8NcTxFFaE1voe-XAT1HWhJalKBlJ8tF_JSvS4JQm-GSBbfAxBujkEIxVYZaUyF0PZeqh3PUw0Yf7mlNjQf-F-6YlkC3gi-lh_mch-W79al9w700cYfvHq_BZloKJQn54fSbfv11_5OeMSc5-AmlcurQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>35353411</pqid></control><display><type>article</type><title>Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Teichert, Friederike ; Verschoyle, Richard D. ; Greaves, Peter ; Thorpe, James F. ; Mellon, J. Kilian ; Steward, William P. ; Farmer, Peter B. ; Gescher, Andreas J. ; Singh, Rajinder</creator><creatorcontrib>Teichert, Friederike ; Verschoyle, Richard D. ; Greaves, Peter ; Thorpe, James F. ; Mellon, J. Kilian ; Steward, William P. ; Farmer, Peter B. ; Gescher, Andreas J. ; Singh, Rajinder</creatorcontrib><description>Urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents a non‐invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer‐related alterations in oxidative stress. We describe the development and validation of two separate liquid chromatography/tandem mass spectrometry (LC/MS/MS) selected reaction monitoring (SRM) methods for the determination of 8‐oxodG and creatinine in both murine and human urine using stable isotope labelled internal standards. Levels of 8‐oxodG were normalised to creatinine. The LC/MS/MS methods were applied to two chemoprevention studies utilising tea polyphenols in humans and TRAMP (TRansgenic Adenocarcinoma of the Mouse Prostate) mice. Patients with benign prostatic hyperplasia received 1 g/day of green tea polyphenols (GTP), 1 g/day of black tea theaflavins (BTT) or no treatment for 4 weeks. TRAMP mice received GTP (0.05% in drinking water) for 4 or 25 weeks. Prostate pathology in TRAMP mice was not affected by GTP. Levels of 8‐oxodG were not altered by tea polyphenols in either mice or humans. In TRAMP mice, urinary 8‐oxodG levels were elevated with increasing age (p < 0.0001) but not changed by the presence of prostate tumours. In conclusion, the LC/MS/MS SRM methods described here are ideally suited for the accurate determination of 8‐oxodG and creatinine in urine samples from both clinical and pre‐clinical studies. Copyright © 2008 John Wiley & Sons, Ltd.</description><identifier>ISSN: 0951-4198</identifier><identifier>ISSN: 1097-0231</identifier><identifier>EISSN: 1097-0231</identifier><identifier>DOI: 10.1002/rcm.3873</identifier><identifier>PMID: 19072863</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Adenocarcinoma - urine ; Animals ; Antineoplastic Agents - administration & dosage ; Antineoplastic Agents - pharmacokinetics ; Cell Line, Tumor ; Chromatography, High Pressure Liquid - methods ; Creatinine - urine ; Deoxyguanosine - analogs & derivatives ; Deoxyguanosine - urine ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Plant Extracts - administration & dosage ; Plant Extracts - pharmacokinetics ; Prostatic Neoplasms - urine ; Reproducibility of Results ; Sensitivity and Specificity ; Spectrometry, Mass, Electrospray Ionization - methods ; Tea - chemistry ; Urinalysis - methods</subject><ispartof>Rapid communications in mass spectrometry, 2009-01, Vol.23 (2), p.258-266</ispartof><rights>Copyright © 2008 John Wiley & Sons, Ltd.</rights><rights>Copyright (c) 2008 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873</citedby><cites>FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19072863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teichert, Friederike</creatorcontrib><creatorcontrib>Verschoyle, Richard D.</creatorcontrib><creatorcontrib>Greaves, Peter</creatorcontrib><creatorcontrib>Thorpe, James F.</creatorcontrib><creatorcontrib>Mellon, J. Kilian</creatorcontrib><creatorcontrib>Steward, William P.</creatorcontrib><creatorcontrib>Farmer, Peter B.</creatorcontrib><creatorcontrib>Gescher, Andreas J.</creatorcontrib><creatorcontrib>Singh, Rajinder</creatorcontrib><title>Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies</title><title>Rapid communications in mass spectrometry</title><addtitle>Rapid Commun. Mass Spectrom</addtitle><description>Urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents a non‐invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer‐related alterations in oxidative stress. We describe the development and validation of two separate liquid chromatography/tandem mass spectrometry (LC/MS/MS) selected reaction monitoring (SRM) methods for the determination of 8‐oxodG and creatinine in both murine and human urine using stable isotope labelled internal standards. Levels of 8‐oxodG were normalised to creatinine. The LC/MS/MS methods were applied to two chemoprevention studies utilising tea polyphenols in humans and TRAMP (TRansgenic Adenocarcinoma of the Mouse Prostate) mice. Patients with benign prostatic hyperplasia received 1 g/day of green tea polyphenols (GTP), 1 g/day of black tea theaflavins (BTT) or no treatment for 4 weeks. TRAMP mice received GTP (0.05% in drinking water) for 4 or 25 weeks. Prostate pathology in TRAMP mice was not affected by GTP. Levels of 8‐oxodG were not altered by tea polyphenols in either mice or humans. In TRAMP mice, urinary 8‐oxodG levels were elevated with increasing age (p < 0.0001) but not changed by the presence of prostate tumours. In conclusion, the LC/MS/MS SRM methods described here are ideally suited for the accurate determination of 8‐oxodG and creatinine in urine samples from both clinical and pre‐clinical studies. Copyright © 2008 John Wiley & Sons, Ltd.</description><subject>Adenocarcinoma - urine</subject><subject>Animals</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antineoplastic Agents - pharmacokinetics</subject><subject>Cell Line, Tumor</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Creatinine - urine</subject><subject>Deoxyguanosine - analogs & derivatives</subject><subject>Deoxyguanosine - urine</subject><subject>Humans</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Plant Extracts - administration & dosage</subject><subject>Plant Extracts - pharmacokinetics</subject><subject>Prostatic Neoplasms - urine</subject><subject>Reproducibility of Results</subject><subject>Sensitivity and Specificity</subject><subject>Spectrometry, Mass, Electrospray Ionization - methods</subject><subject>Tea - chemistry</subject><subject>Urinalysis - methods</subject><issn>0951-4198</issn><issn>1097-0231</issn><issn>1097-0231</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp90UGP1CAUAGBiNO7sauIvMJzUS3eh0NJ624y6a7JqNBtNvBBaXnfQAl1o1-nNP-TFn-QvkbGjnjQc4PE-XoCH0ANKjikh-Ulo7TGrBLuFVpTUIiM5o7fRitQFzTitqwN0GOMnQigtcnIXHdCaiLwq2Qp9ewYjBGucGo132He4yvzWZ_mPr98zDX47X03K-WgcYOU0bgMk6XahcdhO4XdiM1nl8BI3M-7N9WQS3wRv1eivgho288mYJFhsVYw4DtCOKQtjmJ9iNQy9aZdLjD6dA-uHADfgfm3FcdIG4j10p1N9hPv7-Qhdvnh-uT7PLt6cvVyfXmQtT6_KFADvVKdz6ERZsq5mbZVzWnKtlRBNydKi1jpvGq5EThqqGSUFbyg0QqRvPEKPl7JD8NcTxFFaE1voe-XAT1HWhJalKBlJ8tF_JSvS4JQm-GSBbfAxBujkEIxVYZaUyF0PZeqh3PUw0Yf7mlNjQf-F-6YlkC3gi-lh_mch-W79al9w700cYfvHq_BZloKJQn54fSbfv11_5OeMSc5-AmlcurQ</recordid><startdate>20090130</startdate><enddate>20090130</enddate><creator>Teichert, Friederike</creator><creator>Verschoyle, Richard D.</creator><creator>Greaves, Peter</creator><creator>Thorpe, James F.</creator><creator>Mellon, J. Kilian</creator><creator>Steward, William P.</creator><creator>Farmer, Peter B.</creator><creator>Gescher, Andreas J.</creator><creator>Singh, Rajinder</creator><general>John Wiley & Sons, Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><scope>7ST</scope><scope>C1K</scope><scope>SOI</scope></search><sort><creationdate>20090130</creationdate><title>Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies</title><author>Teichert, Friederike ; Verschoyle, Richard D. ; Greaves, Peter ; Thorpe, James F. ; Mellon, J. Kilian ; Steward, William P. ; Farmer, Peter B. ; Gescher, Andreas J. ; Singh, Rajinder</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adenocarcinoma - urine</topic><topic>Animals</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antineoplastic Agents - pharmacokinetics</topic><topic>Cell Line, Tumor</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Creatinine - urine</topic><topic>Deoxyguanosine - analogs & derivatives</topic><topic>Deoxyguanosine - urine</topic><topic>Humans</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Plant Extracts - administration & dosage</topic><topic>Plant Extracts - pharmacokinetics</topic><topic>Prostatic Neoplasms - urine</topic><topic>Reproducibility of Results</topic><topic>Sensitivity and Specificity</topic><topic>Spectrometry, Mass, Electrospray Ionization - methods</topic><topic>Tea - chemistry</topic><topic>Urinalysis - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teichert, Friederike</creatorcontrib><creatorcontrib>Verschoyle, Richard D.</creatorcontrib><creatorcontrib>Greaves, Peter</creatorcontrib><creatorcontrib>Thorpe, James F.</creatorcontrib><creatorcontrib>Mellon, J. Kilian</creatorcontrib><creatorcontrib>Steward, William P.</creatorcontrib><creatorcontrib>Farmer, Peter B.</creatorcontrib><creatorcontrib>Gescher, Andreas J.</creatorcontrib><creatorcontrib>Singh, Rajinder</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Environment Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Environment Abstracts</collection><jtitle>Rapid communications in mass spectrometry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teichert, Friederike</au><au>Verschoyle, Richard D.</au><au>Greaves, Peter</au><au>Thorpe, James F.</au><au>Mellon, J. Kilian</au><au>Steward, William P.</au><au>Farmer, Peter B.</au><au>Gescher, Andreas J.</au><au>Singh, Rajinder</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies</atitle><jtitle>Rapid communications in mass spectrometry</jtitle><addtitle>Rapid Commun. Mass Spectrom</addtitle><date>2009-01-30</date><risdate>2009</risdate><volume>23</volume><issue>2</issue><spage>258</spage><epage>266</epage><pages>258-266</pages><issn>0951-4198</issn><issn>1097-0231</issn><eissn>1097-0231</eissn><abstract>Urinary 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine (8‐oxodG) represents a non‐invasive biomarker for oxidative stress and may be useful for monitoring chemotherapeutic and chemopreventive interventions associated with cancer‐related alterations in oxidative stress. We describe the development and validation of two separate liquid chromatography/tandem mass spectrometry (LC/MS/MS) selected reaction monitoring (SRM) methods for the determination of 8‐oxodG and creatinine in both murine and human urine using stable isotope labelled internal standards. Levels of 8‐oxodG were normalised to creatinine. The LC/MS/MS methods were applied to two chemoprevention studies utilising tea polyphenols in humans and TRAMP (TRansgenic Adenocarcinoma of the Mouse Prostate) mice. Patients with benign prostatic hyperplasia received 1 g/day of green tea polyphenols (GTP), 1 g/day of black tea theaflavins (BTT) or no treatment for 4 weeks. TRAMP mice received GTP (0.05% in drinking water) for 4 or 25 weeks. Prostate pathology in TRAMP mice was not affected by GTP. Levels of 8‐oxodG were not altered by tea polyphenols in either mice or humans. In TRAMP mice, urinary 8‐oxodG levels were elevated with increasing age (p < 0.0001) but not changed by the presence of prostate tumours. In conclusion, the LC/MS/MS SRM methods described here are ideally suited for the accurate determination of 8‐oxodG and creatinine in urine samples from both clinical and pre‐clinical studies. Copyright © 2008 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>19072863</pmid><doi>10.1002/rcm.3873</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0951-4198 |
ispartof | Rapid communications in mass spectrometry, 2009-01, Vol.23 (2), p.258-266 |
issn | 0951-4198 1097-0231 1097-0231 |
language | eng |
recordid | cdi_proquest_miscellaneous_901667630 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Adenocarcinoma - urine Animals Antineoplastic Agents - administration & dosage Antineoplastic Agents - pharmacokinetics Cell Line, Tumor Chromatography, High Pressure Liquid - methods Creatinine - urine Deoxyguanosine - analogs & derivatives Deoxyguanosine - urine Humans Male Mice Mice, Inbred C57BL Plant Extracts - administration & dosage Plant Extracts - pharmacokinetics Prostatic Neoplasms - urine Reproducibility of Results Sensitivity and Specificity Spectrometry, Mass, Electrospray Ionization - methods Tea - chemistry Urinalysis - methods |
title | Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography/tandem mass spectrometry: application to chemoprevention studies |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A29%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%208-oxo-2%E2%80%B2-deoxyguanosine%20and%20creatinine%20in%20murine%20and%20human%20urine%20by%20liquid%20chromatography/tandem%20mass%20spectrometry:%20application%20to%20chemoprevention%20studies&rft.jtitle=Rapid%20communications%20in%20mass%20spectrometry&rft.au=Teichert,%20Friederike&rft.date=2009-01-30&rft.volume=23&rft.issue=2&rft.spage=258&rft.epage=266&rft.pages=258-266&rft.issn=0951-4198&rft.eissn=1097-0231&rft_id=info:doi/10.1002/rcm.3873&rft_dat=%3Cproquest_cross%3E35353411%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4863-aee4fafd2ef7663f93c824164dda77b634dd9dd2bb4a720b1d31054b1eb77873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=35353411&rft_id=info:pmid/19072863&rfr_iscdi=true |